589 related articles for article (PubMed ID: 31762218)
1. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis.
Wang H; Guo X; Zhou J; Li Y; Duan L; Si X; Zhang L; Liu X; Wang M; Shi J; Zhang L
Thorac Cancer; 2020 Jan; 11(1):191-197. PubMed ID: 31762218
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor].
Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Liu X; Wang M; Shi J; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Oct; 22(10):621-626. PubMed ID: 31650943
[TBL] [Abstract][Full Text] [Related]
3. Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
Liu X; Wang Z; Zhao C; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Li Y; Wang M; Zhang M; Zhang L
Thorac Cancer; 2020 Mar; 11(3):810-818. PubMed ID: 32017399
[TBL] [Abstract][Full Text] [Related]
4. Management of immune checkpoint inhibitor-related dermatologic adverse events.
Si X; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Wang M; Zhang L
Thorac Cancer; 2020 Feb; 11(2):488-492. PubMed ID: 31814310
[TBL] [Abstract][Full Text] [Related]
5. Management of immune checkpoint inhibitor-related rheumatic adverse events.
Zhou J; Wang H; Guo X; Wang Q; Duan L; Si X; Zhang L; Liu X; Li Y; Zhang W; Zhang L
Thorac Cancer; 2020 Jan; 11(1):198-202. PubMed ID: 31762209
[TBL] [Abstract][Full Text] [Related]
6. Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections.
Lu M; Zhang L; Li Y; Wang H; Guo X; Zhou J; Duan L; Si X; Xu Y; Zhang L
Thorac Cancer; 2020 Mar; 11(3):805-809. PubMed ID: 31970940
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management.
Zhang Q; Tang L; Zhou Y; He W; Li W
Front Immunol; 2021; 12():663986. PubMed ID: 34122422
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnosis and treatment of immune checkpoint inhibitors-related endocrine dysfunction.
Duan L; Wang L; Wang H; Si X; Zhang L; Liu X; Li Y; Guo X; Zhou J; Zhu H; Zhang L
Thorac Cancer; 2020 Apr; 11(4):1099-1104. PubMed ID: 32043816
[TBL] [Abstract][Full Text] [Related]
9. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events.
Zhuang J; Du J; Guo X; Zhou J; Duan L; Qiu W; Si X; Zhang L; Li Y; Liu X; Wang H; Zhou D; Zhang L
Thorac Cancer; 2020 Mar; 11(3):799-804. PubMed ID: 32017466
[TBL] [Abstract][Full Text] [Related]
10. Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive system.
Li Y; Kang X; Wang H; Guo X; Zhou J; Duan L; Si X; Zhang L; Liu X; Qian J; Zhang L
Thorac Cancer; 2020 Apr; 11(4):829-834. PubMed ID: 32107847
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitor-Related Pneumonitis.
Gomatou G; Tzilas V; Kotteas E; Syrigos K; Bouros D
Respiration; 2020; 99(11):932-942. PubMed ID: 33260191
[TBL] [Abstract][Full Text] [Related]
12. Management of immune checkpoint inhibitor-related adverse events: A review of case reports.
Si X; Song P; Ni J; Di M; He C; Zhang L; Liu X; Li Y; Wang H; Guo X; Zhou J; Duan L; Yang X; Wang M; Zhang L
Thorac Cancer; 2020 Mar; 11(3):498-504. PubMed ID: 31970923
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond.
Reuss JE; Suresh K; Naidoo J
Curr Oncol Rep; 2020 May; 22(6):56. PubMed ID: 32415399
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis.
Lin X; Deng J; Deng H; Yang Y; Sun N; Zhou M; Qin Y; Xie X; Li S; Zhong N; Song Y; Zhou C
Front Immunol; 2021; 12():818492. PubMed ID: 35095920
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management.
Lin MX; Zang D; Liu CG; Han X; Chen J
Front Immunol; 2024; 15():1266850. PubMed ID: 38426102
[TBL] [Abstract][Full Text] [Related]
16. Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related adverse reactions in the nervous system.
Shi J; Niu J; Shen D; Liu M; Tan Y; Li Y; Huang Y; Cui L; Guan Y; Zhang L
Thorac Cancer; 2020 Feb; 11(2):481-487. PubMed ID: 31823509
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection as an underestimated trigger for checkpoint inhibitor-related pneumonitis in lung cancer: a retrospective study.
Lin X; Lu T; Li S; Xie X; Chen X; Jiang J; Qin Y; Xie Z; Liu M; Ouyang M; Zhong N; Song Y; Zhou C
Clin Transl Oncol; 2021 Feb; 23(2):389-396. PubMed ID: 32613413
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in differentiating between checkpoint inhibitor pneumonitis and lung metastasis in a patient with melanoma.
Safa H; Bhosale P; Weissferdt A; Oliva ICG
Immunotherapy; 2020 Apr; 12(5):293-298. PubMed ID: 32295435
[TBL] [Abstract][Full Text] [Related]
19. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society.
Johkoh T; Lee KS; Nishino M; Travis WD; Ryu JH; Lee HY; Ryerson CJ; Franquet T; Bankier AA; Brown KK; Goo JM; Kauczor HU; Lynch DA; Nicholson AG; Richeldi L; Schaefer-Prokop CM; Verschakelen J; Raoof S; Rubin GD; Powell C; Inoue Y; Hatabu H
Chest; 2021 Mar; 159(3):1107-1125. PubMed ID: 33450293
[TBL] [Abstract][Full Text] [Related]
20. Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis.
Huang A; Xu Y; Zang X; Wu C; Gao J; Sun X; Xie M; Ma X; Deng H; Song J; Ren F; Pang L; Qian J; Yu Z; Wan S; Chen Y; Pan L; Zhuang G; Liu S; Xue X
BMC Cancer; 2021 May; 21(1):634. PubMed ID: 34051746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
